Rafarma Pharmaceuticals, Inc. Stock Forecast

Rafarma Pharmaceuticals, Inc. stock downgraded to Sell Candidate
(Updated on Jun 25, 2024)

RAFA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 13, 2024, and so far it has risen 0.656%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Rafarma Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0855. On a fall, the stock will find some support from the short-term average at $0.0611. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rafarma Pharmaceuticals, Inc. stock

Rafarma Pharmaceuticals, Inc. finds support from accumulated volume at $0.0610 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAFA) For The Upcoming Trading Day Of Wednesday 26th

For the upcoming trading day on Wednesday, 26th we expect Rafarma Pharmaceuticals, Inc. to open at $0.0614, and during the day (based on 14 day Average True Range), to move between $0.0568 and $0.0660, which gives a possible trading interval of +/-$0.0046 (+/-7.44%) up or down from last closing price. If Rafarma Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 14.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0610 (0.65%) than the resistance at $0.0670 (9.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Rafarma Pharmaceuticals, Inc. stock A Buy?

Rafarma Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.487 Sell Candidate Downgraded

Predicted Opening Price for Rafarma Pharmaceuticals, Inc. of Wednesday, June 26, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.